Trump Administration Ends Program Critical to Search for an H.I.V. Vaccine
- The Trump administration ended a $258 million HIV vaccine research program critical to global efforts on May 30, 2025.
- This decision followed a National Institutes of Health review that withdrew support for key programs at Duke and Scripps Research.
- The cut affected broadly neutralizing antibody research and paused Moderna's clinical HIV vaccine trials, delaying vaccine development.
- Experts like Mitchell Warren called the move an 'intentional unraveling of America’s legacy in global health,' warning of lasting consequences.
- This funding removal threatens decades of progress and could impede efforts to end the HIV pandemic without a vaccine.
Insights by Ground AI
Does this summary seem wrong?
17 Articles
17 Articles
All
Left
4
Center
2
Right
1
Coverage Details
Total News Sources17
Leaning Left4Leaning Right1Center2Last UpdatedBias Distribution57% Left
Bias Distribution
- 57% of the sources lean Left
57% Left
L 57%
C 29%
14%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage